Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under:
Commercial paper (Rs 5,000 crore) - CRISIL A1+
Non convertible debentures (Rs 4,600 crore) - CRISIL AA+/ Stable
Non convertible debentures (Rs 400 crore) - CRISIL AA+/ Stable
Total bank loan facilities rated (Rs 1,250 crore) - CRISIL AA+/ Stable
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
